Musely lands $360M from General Catalyst without giving up equity

Musely has secured $360 million from General Catalyst in a financing deal that did not require the company to sell equity, a notable structure at a time when many private tech companies are still weighing valuation pressure against the need for fresh capital.

The company, known for its telehealth-driven skincare business, is taking on a large pool of funding while preserving existing ownership stakes. That alone makes the deal stand out. In a market where venture funding has become more selective, non-dilutive capital can be especially attractive for companies that want to keep control and avoid resetting expectations through a traditional equity round.

For Musely, the headline is not just the size of the financing. It is the format.

Raising hundreds of millions of dollars without giving up equity suggests the company and its backers see a path to growth that does not depend on the usual venture playbook. Instead of selling a slice of the business, Musely is tapping a financing structure that gives it room to invest while leaving its cap table intact.

That matters in tech well beyond this one company. Founders and existing investors have become increasingly interested in alternatives to straight equity raises, especially when companies have predictable revenue, clear unit economics, or businesses that can support more creative capital arrangements.

Musely sits in a category that has drawn steady attention: consumer-facing healthcare delivered through software. Telehealth platforms that combine digital consultation, prescription workflows, and direct product fulfillment have been working to prove they can scale efficiently while staying within a complex healthcare framework. Skincare, in particular, has become one of the more visible corners of that market because it blends recurring consumer demand with medical oversight and online convenience.

Fresh funding could give Musely more room to expand operations, invest in product development, support marketing, or deepen its healthcare infrastructure. The company’s exact next steps were not detailed in the source material, but a financing round of this size typically signals an ambition to move faster.

General Catalyst has increasingly positioned itself as a firm willing to work across different forms of company building and financing, not just traditional venture checks. This deal fits that broader shift. Capital providers are looking for more tailored ways to back companies, especially in sectors where business performance may justify structures outside the usual equity round.

There is also a broader signal here for startups watching from the sidelines. The venture market is no longer operating under a one-size-fits-all model. If a company has enough traction, lenders and investors may be more open to bespoke deals that reflect the underlying business rather than forcing a standard fundraising script.

That does not mean non-dilutive capital is easy money. It usually comes with its own requirements, expectations, and risk profile. But for companies that can support it, the appeal is obvious: more cash, less ownership loss.

For now, Musely’s financing stands as a sharp example of how startup funding is evolving. In 2026, getting a big check is still news. Getting one without giving away equity is the part that really turns heads.